Nu Skin Enterprises, Inc.
NYSE:NUSHousehold & Personal Products
+$0.13 today
- Market cap
- $188.38M
- Beta
- 0.95
- P/E (TTM)
- 4.5
- EPS (TTM)
- $1.13
- Dividend yield
- 4.70%
Volume 0.59M
Average 0.57M
NUS Operating Income
Profit from core operations after operating expenses, before interest and taxes.
Nu Skin Enterprises, Inc.NYSE: NUS
Operating Income · Q1 FY2026 · quarter ended Mar 2026
Operating income turns positive
Q1 FY2026 operating income was $5.87M, compared with -$9.9M a year earlier. Trailing-twelve-month operating income was $81.53M. Over 3 fiscal years it compounded at -6.4% a year.
Context
- Operating income amounted to 6.1% of revenue in FY2025, down 2.6 pp from a year earlier.
- Operating income increased in 1 of the last 3 fiscal years.
What to watch
Whether operating income reaches the consensus estimate from 1 analysts of $63.76M (-29.8%) for the fiscal year ending Dec 2026, a slowdown from the +160.0% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $5.87M-74.8% QoQ
- Last fiscal yearDec 2025
- $90.88M+160.0% YoY
- LTMMar 2026
- $81.53M+147.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +159.2% | -45.4% | -204.6 pp |
| 1 year | +160.0% | -29.8% | -189.8 pp |
| 3-year CAGR | -6.4% | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Income history
USD · from the income statement
- Latest · FY2025
- 90.88M USD
- Year-over-year change
- +160.0%
- 4-year CAGR
- -21.1%
| Period | Period end | Operating Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 90.88M | +160.0% |
| FY2024 | 2024-12-31 | (151.59M) | -414.0% |
| FY2023 | 2023-12-31 | 48.27M | -56.5% |
| FY2022 | 2022-12-31 | 110.85M | -52.6% |
| FY2021 | 2021-12-31 | 233.99M | — |
Operating Income vs competitors
How NUS compares with its peers on the latest reported figures
- NUS's LTM Mar 2026 operating income of $81.53M is the highest of the 8 companies compared; the peer median is -$60.49M.
- Its year-over-year change of +147.9% is the highest of 8, against a peer median of -5.5%.
- Operating income amounts to 5.7% of revenue for NUS, versus a peer median of 8.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $81.53M | +147.9% | -6.4% | 5.7% | |
| LTM Apr 2026 | $67.19M | -5.5% | +22.8% | 2.8% | |
| LTM Mar 2026 | $57.57M | +43.5% | — | 8.7% | |
| LTM Mar 2026 | $33.13M | +75.9% | +22.5% | 6.1% | |
| LTM Mar 2026 | -$60.49M | +65.5% | — | 6.8% | |
| LTM Mar 2026 | -$218.25M | -37.4% | — | 82.4% | |
| LTM Mar 2026 | -$267.07M | -696.6% | — | 51.2% | |
| LTM Feb 2026 | -$702.91M | -592.4% | -20.4% | 39.3% | |
| Peer median (excluding NUS) | -$60.49M | -5.5% | +22.5% | 8.7% | |
Competitors are the stored peer set for NUS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.7B | 2.23B | 1.97B | 1.73B | 1.49B |
| Cost of Revenue | 675.22M | 630.92M | 611.85M | 550.23M | 453.76M |
| Gross Profit | 2.02B | 1.59B | 1.36B | 1.18B | 1.03B |
| Gross Margin | 75.0% | 71.7% | 68.9% | 68.2% | 69.4% |
| Research & Development | 27.2M | 0 | 22.6M | 13M | 0 |
| Selling, General & Admin | 1.73B | 1.44B | 1.29B | 1.13B | 940.52M |
| Operating Expenses | 1.79B | 1.48B | 1.31B | 1.33B | 940.52M |
| Depreciation & Amortization | 125.02M | 72.51M | 69.22M | 69.81M | 52.26M |
| EBITDA | 368.48M | 174.97M | 202.98M | (78.83M) | 262.41M |
| EBITDA Margin | 13.7% | 7.9% | 10.3% | -4.6% | 17.7% |
| Operating Income | 233.99M | 110.85M | 48.27M | (151.59M) | 90.88M |
| Operating Margin | 8.7% | 5.0% | 2.5% | -8.8% | 6.1% |
| Interest Income | 11.16M | 10.38M | 0 | 0 | 0 |
| Interest Expense | 11M | 21.88M | 25.56M | 26.41M | 13.95M |
| Other Income / Expenses | (1.53M) | (21.88M) | (21.69M) | (23.47M) | 105.32M |
| Income Before Tax | 232.46M | 88.97M | 26.58M | (175.05M) | 196.2M |
| Pre-Tax Margin | 8.6% | 4.0% | 1.3% | -10.1% | 13.2% |
| Income Tax Expense | 85.19M | (15.81M) | 17.98M | (28.46M) | 35.99M |
| Net Income | 147.27M | 104.78M | 8.6M | (146.59M) | 160.2M |
| Net Margin | 5.5% | 4.7% | 0.4% | -8.5% | 10.8% |
| EPS (Basic) | 2.93 | 2.10 | 0.17 | (2.95) | 3.25 |
| EPS (Diluted) | 2.86 | 2.07 | 0.17 | (2.95) | 3.18 |
| Weighted Avg Shares | 50.19M | 50M | 49.71M | 49.66M | 49.29M |
| Weighted Avg Shares (Diluted) | 51.43M | 50.53M | 49.86M | 49.66M | 50.3M |
Nu Skin Enterprises, Inc.
NYSE:NUS
Intrinsic Alpha fair value
Locked
Current Price
$3.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.